Search

A recent preprint abstract discusses the use of computational methods to identify potential protein targets for small molecule drug development. The researchers used machine learning, public databases, and structural analysis to focus on autoimmune diseases and identified IL12B as a promising candidate. They found a potential small molecule binding site involved in dimer formation, which could lead to more precise and effective treatments for conditions like inflammatory bowel disease. It is important to note that this research has not yet undergone peer review. [Extracted from the article]

Researchers from Hunan University in the People's Republic of China have developed a new method for predicting drug-target affinity (DTA) in the early stages of drug discovery. The method, called GAL-DTA, uses deep learning and generative active learning to enhance the training of the predictor. By directly generating diverse and informative data, GAL-DTA reduces annotation costs while maintaining model performance. Extensive experiments on independent test sets showed that GAL-DTA achieved superior performance, with an average reduction of 8.402% in mean squared error. This research has been peer-reviewed and published in Information Sciences. [Extracted from the article]

A recent study from the University of Dundee explores the challenges and potential solutions in drug development for male subfertility. The review highlights the limited treatment options available for men with infertility, aside from in-vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI). The traditional drug discovery pathway is time-consuming and resource-intensive, often resulting in failed therapies. However, innovative approaches such as high-throughput screening, combinatorial chemistry, and repurposing established medications show promise in accelerating drug development for male subfertility. The study suggests that scientific advancements may offer feasible solutions to address this issue. [Extracted from the article]

A study conducted by Shanghai Jiao Tong University in China has found that derived organoids (PDOs) show promise as a platform for clinical and translational studies in cancer research. The study highlights the strong correlation between clinical outcomes and the use of PDOs to predict the efficacy of chemotherapy and radiotherapy. The researchers propose guidelines for standardizing PDO-based drug sensitivity testing (DST) and identify major challenges in clinical prediction when utilizing PDOs. This research provides valuable insights for cancer precision medicine and drug development. [Extracted from the article]

A report from Zhejiang University discusses the advancements in organ-on-a-chip technology for drug development. Traditional drug development is a lengthy and costly process with high failure rates, prompting the pharmaceutical industry to seek more efficient frameworks. Organ-on-a-chip systems offer a more accurate simulation of human organ microenvironments and physiological responses, providing a cost-effective and efficient platform for biomedical research. These systems enable real-time analysis, high-throughput experimentation, and automation, showing promise in enhancing the drug development process. The report focuses on the manufacturing, design, sensing systems, and applications of organ-on-a-chip systems, highlighting their capabilities and technical challenges. [Extracted from the article]

A recent report from the Chinese Academy of Medical Sciences in Beijing, People's Republic of China, discusses the design and synthesis of a novel PSMA-PI3K small molecule drug conjugate for targeted cancer therapy. The conjugate demonstrated potent inhibition against PI3K and selectively inhibited the growth of PSMA-positive cancer cells. In vivo evaluation showed favorable efficacy and tolerability in a xenograft model, suggesting potential application in targeted cancer therapy. Financial support for this research came from the CAMS Innovation Fund for Medical Sciences. [Extracted from the article]

A new study on drug development in South Asia has been published by researchers at Certara USA Inc. The study summarizes the outcomes of a conference organized by the South Asian College of American College of Clinical Pharmacology (SAC-ACCP) in July 2023 in Bhopal, India. The conference focused on advancing pediatric drug development in South Asia and featured presentations by experts from the pharmaceutical industry, regulatory agencies, and independent consultancies. The study provides insights from the conference and connects to similar discussions that occurred in 2017. For more information, the full article can be accessed for free online. [Extracted from the article]

Researchers at Princess Nourah Bint Abdulrahman University in Riyadh, Saudi Arabia have conducted a study on the antiproliferative activity of new indole-based aromatase/iNOS inhibitors. The study evaluated the efficacy of these inhibitors against various cancer cell lines and found that compounds 12 and 16 showed exceptional activity. The researchers also investigated the apoptotic potential of these compounds and discussed their binding interactions with the aromatase active site. The study concluded that these compounds have potential as therapeutic agents with reduced toxicity. [Extracted from the article]

Researchers at the University of Liverpool have developed a library of strains that can be used to create new antibacterial compounds to combat antimicrobial resistance (AMR) in Acinetobacter baumannii bacteria. A. baumannii is a common opportunistic pathogen that causes serious infections, particularly in hospitalized or immunocompromised patients. The strains created by the researchers will aid in studying the effectiveness of anti-Acinetobacter compounds and contribute to global preparedness against multi-drug resistant A. baumannii infections. This innovative approach offers a powerful tool for studying novel therapeutics and complex resistance networks in A. baumannii. [Extracted from the article]

A recent preprint abstract discusses the development of a non-diffusive proximity tagging system called POST-IT (Pup-On-target for Small molecule Target Identification Technology). This system aims to address the limitations of current target identification methods by allowing for the identification of target proteins in live cells and organisms. POST-IT successfully identified known targets and discovered new binders for certain drugs, enhancing our understanding of their mechanisms of action. The researchers also demonstrated the application of POST-IT in live zebrafish embryos, suggesting its potential for broad biological research and drug development. However, it is important to note that this preprint has not yet undergone peer review. [Extracted from the article]

The article discusses the development of a database called scDrugAtlas, which aims to integrate single-cell drug response data for the study of tumor heterogeneity and drug resistance. The database contains over 100 datasets with single-cell drug response information from various sources, including cell lines, mouse models, patient samples, and bacteria. It covers 66 unique drugs and 13 major cancer types, providing valuable information for the development of computational models and the identification of drug-resistant tumor cells. The scDrugAtlas database is accessible online and can be a useful resource for researchers in the field of bioinformatics and biologists studying drug resistance mechanisms. [Extracted from the article]

A recent study conducted at Superior University in Punjab, Pakistan, focused on the development of a more affordable prosthetic suspension system for transtibial amputees. The researchers created and tested a locally-made Shuttle Lock suspension system, which was well-received by users. The system provided a comfortable, secure, and durable solution for transtibial prosthesis users, although some minor difficulties were noted. Overall, the study highlights the importance of a well-designed suspension system in improving the mobility and satisfaction of amputees. [Extracted from the article]

A recent research report from Ninevah University in Mosul, Iraq explores the pharmacokinetic and toxicity profiles of certain coumarin-heterocycle hybrids using machine learning-based models. The study utilizes three online tools to predict the pharmaceutical traits of these hybrids, including their physicochemical properties, water solubility, lipophilicity, and drug likeness attributes. The report identifies several hybrids that show promise for oral administration and possess lead-like properties, making them potential candidates for therapeutic development. However, the study also highlights the need to modify the molecular structures of these compounds to improve their pharmacokinetics and toxicity characteristics. [Extracted from the article]

A recent study conducted by the Faculty of Pharmacy has examined the pharmacological effects of dexpanthenol. The study found that dexpanthenol has protective effects on various organs and systems in the body, including the kidneys, liver, brain, nerves, gastrointestinal tract, cardiovascular system, and respiratory system. The research suggests that further investigation into the pleiotropic effects of dexpanthenol is warranted, particularly exploring alternative methods of administration such as oral administration. The development of various dosage forms of dexpanthenol, including gels, wound dressings, ophthalmic films, and capsules, has the potential to expand its clinical applications in fields such as dermatology, gastroenterology, neurology, and general internal medicine. [Extracted from the article]

A preprint abstract from biorxiv.org discusses the genome-editing potential of DNA nucleases TnpB and IscB in Escherichia coli (E. coli) strains. The study found that TnpB only worked in E. coli MG1655, while IscB and enIscB were effective in ATCC9637 and BL21(DE3). The researchers also explored the impact of editing efficiency by changing the copy number of TnpB/IscB/enIscB and successfully cured the editing plasmids. The study concludes that the application of TnpB/IscB/enIscB in genome-editing in E. coli will expand the genetic manipulation toolbox and aid in the development of new antimicrobial drugs. However, it is important to note that this preprint has not been peer-reviewed. [Extracted from the article]

The University of Padova has published new research on translational myology in the European Journal of Translational Myology. The research includes an article by Roger Sabbadini, who reflects on his time as a guest scientist at the Institute of General Pathology of the University of Padua and his collaboration with Professor Giovanni Salviati. The article also announces the addition of a new section to the journal's editorial board and invites readers to contribute typescripts. Additionally, the article promotes the International Meeting: Padua Days on Muscle and Mobility Medicine, which will take place in March 2025. The preliminary program is included, and abstracts and registration forms are due by November 15, 2024. For more information, readers can contact Ugo Carraro at the University of Padova. [Extracted from the article]

A recent study conducted in New Delhi, India, has explored advancements in trifluoromethylation strategies for indoles, oxindoles, and indolines. The researchers highlight the potential of combining fluorine and indole to enhance drug development. The study examines two types of strategies for trifluoromethylation reactions, including direct installation of a CF3 group and cyclization reactions. The research concludes by discussing the substrate scope and mechanism of these reactions. This peer-reviewed study provides valuable insights into the synthesis of these compounds. [Extracted from the article]

A recent study conducted by researchers at Amity University focused on the determination of Mannitol in injectable formulations. Mannitol is a substance derived from natural alcohols found in plants and fruits, and it is commonly used in neurosurgery and neurology to reduce ocular pressure and promote dehydration. The researchers aimed to develop a simple, economical, sensitive, and accurate spectrophotometry method for the determination of Mannitol, as existing chromatography methods are often tedious and expensive. The developed method was successfully validated and utilized for the analysis of marketed formulations. [Extracted from the article]

Researchers at Washington University in St. Louis have made new findings on drug resistance. They believe that complex signaling pathways are responsible for drug resistance, and that drug combinations targeting multiple signaling targets could reduce resistance. The researchers developed a novel integrative and interpretable graph AI model called DeepSignalingFlow to uncover the mechanisms of synergy in drug combinations. The model outperformed existing graph AI models in predicting synergy scores and can interpret the core signaling flows. The research is published in npj Systems Biology and Applications. [Extracted from the article]

A study conducted in Andhra Pradesh, India, assessed the knowledge, attitude, and practice of drug repurposing among doctors. Drug repurposing involves exploring existing drugs developed for one condition for their potential efficacy in treating different diseases. The study found that there is a knowledge gap among physicians regarding drug repurposing and off-label drug use. The researchers suggest the need for conferences and seminars to educate doctors on this topic. [Extracted from the article]

Researchers from Jan Kochanowski University in Kielce, Poland have conducted a study on the antiproliferative activity of cyclometalated Ir(III) complexes. The study involved the synthesis of four new complexes and their characterization using various physicochemical methods. The researchers also investigated the cytotoxic properties of the complexes and their interactions with DNA and BSA. The study concluded with the evaluation of the cytotoxic activity of the complexes against different cell lines. This research provides valuable insights into the development of potential chemotherapeutic agents. [Extracted from the article]

Researchers from Cracow University of Technology in Poland have conducted a study on the potential of titanium dioxide nanoparticles as drug carriers. The study involved modifying the nanoparticles with a galactose coating to reduce the release of harmful titanium ions. The researchers found that the modified nanoparticles exhibited favorable properties for effective drug-carrier interactions and demonstrated enhanced drug absorption in pharmacokinetic studies in rats. The study suggests that these modified titanium dioxide nanoparticles hold promise as efficient drug delivery vehicles in biomedical applications. [Extracted from the article]

A recent report discusses research conducted at Federal University Parana in Curitiba, Brazil, on machine learning and its potential in identifying new anti-HIV drug candidates. The study utilized an integrated approach involving machine learning models, molecular docking, and molecular dynamics simulations to identify compounds that could inhibit the bioactivity of the CC chemokine receptor type 5 (CCR5) protein, a key entry point for the HIV virus. Through this approach, the researchers identified 124 new anti-HIV drug candidates, which were confirmed through further testing. The study highlights the therapeutic potential of these compounds and suggests that the convergence of machine learning and experimental findings could lead to significant advancements in pharmaceutical research. The Python code and associated database used in the study are available on GitHub for reproducibility. [Extracted from the article]

A report from the University of Western Ontario discusses the use of polymer-drug conjugates (PDCs) to improve the properties of drug molecules. These conjugates are designed to release drugs in response to physiological stimuli, such as changes in pH. The report explores different linker strategies and their applications in the development of PDCs for treating cancer, inflammation, and bacterial infection. The research concludes by discussing ongoing challenges and opportunities for future work in this field. This information is available in a peer-reviewed article published in Chemistry of Materials. [Extracted from the article]

Researchers at King Abdulaziz University in Jeddah, Saudi Arabia have conducted a study on cancer treatment targeting the phosphoinositide 3-kinase (PI3K) signaling pathway. Using computational methods, the researchers identified a novel inhibitor for the gene PIK3CG, which encodes the catalytic subunit gamma of PI3K gamma. Through screening and modeling, they found that one compound, 885,387, showed significant therapeutic potential as an inhibitor of the PIK3CG target implicated in cancer. Further experimental investigation is warranted. This research has been peer-reviewed and published in Molecular Diversity. [Extracted from the article]

A recent study conducted by researchers at the LG Household and Health Care R&D Center in Seoul, South Korea, has explored the efficacy of Vitamin B12 and adenosine triphosphate (ATP) in enhancing skin radiance. The study aimed to develop a cosmetic formula that reduces hyperpigmentation and improves skin regeneration. Through the use of artificial intelligence technologies, the researchers identified Vitamin B12 as a molecule that targets melanogenesis, and ATP as a molecule that targets skin regeneration. The application of the Vitamin B12 and ATP complex to one-half of the face in human participants resulted in improved skin radiance, elasticity, and texture. These findings provide valuable insights for the development of skincare formulations. [Extracted from the article]

Researchers at Southern Medical University in Guangzhou, China have discovered potential new strategies for treating hepatic sepsis, a condition that can quickly result in fatality for critically ill individuals. The researchers identified PDE4 as a potential target for the treatment of liver damage associated with sepsis. They discovered a novel PDE4 inhibitor, 4e, which demonstrated better inhibitor activity and improved oral bioavailability compared to existing compounds. In animal models, 4e exhibited excellent hepatoprotective activity against hepatic sepsis. This research provides valuable insights for the development of new drugs to treat sepsis. [Extracted from the article]

Researchers from Qingdao University have developed a deep learning model called MSH-DTI for predicting drug-target interactions. The model uses self-supervised learning methods to obtain drug and target structure features and incorporates a Heterogeneous Interaction-enhanced Feature Fusion Module for multi-graph construction. The model outperformed other models on the DTINet dataset, with AUROC and AUPR values of 0.9620 and 0.9605 respectively. The researchers believe that MSH-DTI is a valuable tool for discovering new drug-target interactions. [Extracted from the article]

A recent study conducted by researchers at Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) in Germany has explored the role of the protein kinase pUL97 in cytomegalovirus (CMV) replication and pathogenesis. The study found that pUL97 interacts with host cyclins and CDKs, which are important for viral replication. This interaction presents potential targets for antiviral drugs. The researchers also discovered that inhibiting pUL97 and CDK7 simultaneously showed promising results in inhibiting CMV replication. This research provides new insights into the regulation of CMV and potential strategies for antiviral drug development. [Extracted from the article]

A recent preprint abstract suggests that Parkinsonism, a condition characterized by motor dysfunction, can be divided into three molecular subgroups in the fruit fly Drosophila. The study used behavioral screening and machine learning to identify three clusters of mutants that converge on different cellular pathways: mitochondrial function, retromer/vesicle trafficking, and proteostasis/autophagy. The findings indicate that familial Parkinsonism can be stratified into these functional groups, which could lead to targeted biomarker discovery and drug development. However, it is important to note that this research has not yet undergone peer review. [Extracted from the article]

A study conducted by researchers at Sun Yat-sen University in Guangzhou, China, has found that dihydromyricetin (DHM), a flavonoid from vine tea, has potential benefits for treating diabetic renal fibrosis. The researchers discovered that DHM effectively suppressed the synthesis of fibrotic and inflammatory adhesion factors in diabetic mice and glomerular mesangial cells. They also found that DHM reduced the activity and protein expression of sphingosine kinase-1 (SphK1), a key regulator of diabetic renal inflammation, which ultimately inhibited the activation of the NF-xB pathway. The study suggests that DHM could be a potential candidate for treating diabetic renal fibrosis. [Extracted from the article]

Researchers at University Hospital RWTH Aachen in Germany have developed physiologically based pharmacokinetic (PBPK) models specifically for rabbits. These models accurately predict the pharmacokinetic profiles of protein therapeutics in rabbits, which are important small animal models in ocular therapeutics. The models take into account various physiological factors and protein parameters, and have shown a strong correlation between predicted and observed serum concentration-time profiles. The researchers believe that these PBPK models provide a promising platform for translating preclinical findings to clinical settings and can contribute to more specific applications of protein therapeutics in ocular drug development. [Extracted from the article]

Researchers from Chengde Medical University in China have developed new antiallergic drugs by synthesizing dicoumarin derivatives. Allergies have been on the rise due to climate change, and the development of new antiallergic drugs has become a priority. The researchers synthesized 14 different dicoumarin derivatives and tested their inhibitory effects on mast cells, finding that some of them showed good antiallergic activity. This study presents a new method for developing antiallergic drugs. [Extracted from the article]

A recent study conducted by researchers at Jeonbuk National University in South Korea aimed to understand the cardiovascular toxicity of cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors, which are used to treat certain types of breast cancer. The study analyzed reports from the FDA Adverse Event Reporting System and found that CDK4/6 inhibitors were associated with cardiovascular adverse events, including hypertension and cardiac failure. The researchers concluded that further research is needed to better understand the mechanisms and risk factors of these cardiovascular toxicities. This information is important for individuals considering or currently using CDK4/6 inhibitors and highlights the need for monitoring and prevention strategies. [Extracted from the article]

A recent report from Zhengzhou University in the People's Republic of China discusses the discovery of 1,2,4-triazole-3-thione derivatives as potent and selective inhibitors for DCN1, a co-E3 ligase involved in various diseases including cancers, heart failure, and fibrotic diseases. The researchers designed and synthesized a new class of inhibitors based on the hit HD1, which was identified through high-throughput screening and optimized through structure-activity-relationship explorations. The final compound, HD2, showed high potency and selectivity as a DCN1 inhibitor, effectively relieving cardiac fibroblast activation and reducing cardiac fibrosis and remodeling. This research provides a promising lead compound for targeting DCN1 in the treatment of pathological cardiac fibrosis and remodeling. [Extracted from the article]

A recent study conducted by researchers at Kashan University of Medical Sciences in Iran examined the use of cosmetics and its side effects on Iranian women. The study found that the highest rate of permanent cosmetic use was among women aged 20-29, while the lowest rate was among women aged 50 and older. The use of cosmetics was influenced by factors such as age, economic-social status, education, and social media. The study also revealed that one-third of women experienced allergies from using cosmetics. The research concluded that enhancing beauty and being seen were the main reasons for using cosmetics among women. [Extracted from the article]

A preprint abstract from biorxiv.org discusses the potential role of hemoglobin (Hb) in neurodegenerative diseases. The study suggests that Hb, which is primarily known for transporting oxygen in red blood cells, also has antioxidant effects in the brain. The researchers developed a small molecule called KDS12025 that enhances Hb's peroxidase activity, reducing harmful hydrogen peroxide (H2O2) levels and mitigating neurodegeneration in Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. However, it is important to note that this research has not yet undergone peer review. [Extracted from the article]

A recent study published in Drug Week highlights the potential for new antiviral drug candidates against Monkeypox. The study utilized computational methods, such as molecular docking and molecular dynamic simulations, to identify compounds that can target specific proteins of the Monkeypox virus. The top-performing molecules, including Dorsilurin K and Mangostin, showed high docking scores and may have a good affinity for binding to the virus proteins. However, further in vitro and in vivo studies are needed to validate these candidates. If successful, these findings could lead to significant breakthroughs in managing Monkeypox. [Extracted from the article]

A recent study conducted at Government College University in Faisalabad, Pakistan, explored the use of nonionic surfactants for the solubilization and delivery of the nootropic drug piracetam. The researchers developed a cluster of micelles using Tween 80 and Triton-X 100 surfactants, and investigated the drug-surfactant interaction in different mediums. The results showed that the solubilization of piracetam was enhanced by mixing an appropriate amount of both surfactants, and the micellar formulations were stable. This research provides insights into the development of nanopharmaceuticals for drug delivery. [Extracted from the article]

A recent study conducted by researchers at the Walter Reed Army Institute of Research has optimized a mouse model of severe sterile inflammation in order to evaluate potential drug candidates for the treatment of systemic inflammatory response syndrome (SIRS) and multiple organ dysfunction syndrome (MODS). The researchers used a tissue-bone matrix (TBX) implanted into mice to mimic the effects of trauma on the body. They found that the use of ketamine/xylazine anesthesia increased the lethality of the TBX, and that Eritoran, an anti-inflammatory drug, was not effective in rescuing the mice from moribundity or mortality. This mouse model provides a valuable screening tool for the evaluation of novel therapeutics against trauma-induced SIRS/MODS. [Extracted from the article]

A recent report from Cluj Napoca, Romania discusses the development of in-house azole compounds with antimicrobial activity. The research group from the Department of Pharmaceutical Chemistry at the University of Medicine and Pharmacy has been actively involved in designing novel antimicrobial drugs. The compounds they developed were based on azolic heterocycles, particularly thiazole. The research explores the evolution of their methodology and presents the development of these compounds over the years. Antimicrobial resistance is a global health threat, and this research aims to contribute to the development of more efficient antimicrobials. [Extracted from the article]

A recent article published in Drug Week discusses the current industry practices for assessing and controlling N-nitrosamines in antibody-drug conjugates (ADCs). ADCs are increasingly being used in oncology therapeutics, and concerns about the presence of N-nitrosamines in pharmaceutical products have led to increased regulatory scrutiny. The article presents the results and analysis from a benchmarking survey of member companies of the IQ Consortium, covering topics such as risk assessment methodology, identification and characterization of risks, and control limits. The research concludes that further development of scientifically sound approaches in this field is encouraged. [Extracted from the article]

A recent study conducted at Sidra Medicine evaluated the accuracy of a direct antimicrobial susceptibility testing (AST) method on pediatric blood culture bottles. The researchers found that performing AST directly on positive blood culture broths can provide accurate susceptibility information quickly, allowing for targeted antibiotic therapy initiation. The study showed high categorical and essential agreements between the direct method and the standard method, indicating its potential to improve clinical outcomes and reduce healthcare costs associated with sepsis. The findings suggest that the direct AST method using the BD Phoenix M50 system can be a valuable tool in guiding antimicrobial therapy for bloodstream infections. [Extracted from the article]